Securities litigation momentum The firm has an active docket of high-profile securities class actions involving major biopharma and consumer tech companies, indicating ongoing demand for complex litigation support and potential expansion of contingent fee arrangements, where plaintiffs’ side expertise complements defense strategies.

Growth through certifications National Woman Owned and WBENC certification positions Faruqi & Faruqi as a preferred diverse-owned firm, offering strategic access to corporate and public sector partners prioritizing supplier diversity and inclusive procurement initiatives.

Expansion-ready practice A mid-sized team with a focus on class actions and shareholder derivative suits suggests capacity to scale in response to rising securities litigation volumes, providing opportunities for co-counseling, referral relationships, and expanded service offerings.

Tech-enabled advantage The technology stack including cloud, AI, and secure communications indicates readiness to support large data-driven litigations, e-discovery, and client collaboration, enabling pitches to large corporate clients seeking efficient, tech-forward litigation partners.

Market positioning Recent case filings against Embecta, Regeneron, Insulet, and other notable issuers highlight a defensible market niche in complex civil and securities actions, with room to differentiate through rigorous discovery, governance-focused derivative work, and investor advocacy services.